))
Trending News US – February 8, 2024
Manage episode 399926809 series 3046075
Content provided by Vynamic. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Vynamic or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In this episode, Jen sits down with Vynamic’s Deal Activation & Partnership Enablement Service Leads, Senior Director Kevin Fletcher and Executive Sean Martin, to discuss recent newsworthy items coming out of the J.P. Morgan Healthcare Conference, including the major acquisitions and deals announced, particularly those focused on AI and digital innovation.
Check out Vynamic’s Deal Activation & Partnership Enablement Service page to learn more about how Vynamic helps clients manage critical, time-sensitive activities across the deal life cycle.
Podcast Tags: healthcare, healthcare news, life sciences, pharmaceutical, JP Morgan, deal activation, partnerships, mergers, acquisitions, AI, digital innovation
Source Links:
- Inizio Biotech key takeaways from JPM industry event
- Cigna sells Medicare business to Health Care Service for $3.3 bln
- Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
- J&J, Merck and Boston Scientific Go on $6.4 Billion Buying Spree
- Amazon rolls out digital health benefits program, taps Omada Health as launch partner
- What the Health Care Sector Was Selling at the J.P. Morgan Confab
- Jefferson Health says LVHN merger would double its insurance business within 2 years
Panel – Jen Burke, Kevin Fletcher, Sean Martin
Research & Production – Anna Briccetti, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
210 episodes
Share
